These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 12591459)

  • 1. Successful living donor liver transplantation in a patient with preoperative fungal infection.
    Tsuchiya T; Abe T; Saito T; Sato Y; Kenjo A; Yamada F; Asari S; Nishi I; Tanaka K; Gotoh M
    Transplant Proc; 2003 Feb; 35(1):401. PubMed ID: 12591459
    [No Abstract]   [Full Text] [Related]  

  • 2. Pattern of bacterial and fungal infections in the first 3 months after pediatric living donor liver transplantation: an 11-year single-center experience.
    Nafady-Hego H; Elgendy H; Moghazy WE; Fukuda K; Uemoto S
    Liver Transpl; 2011 Aug; 17(8):976-84. PubMed ID: 21786404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of pretransplantation bacterial and fungal culture positivity on outcome after living donor liver transplantation.
    Kim BS; Lee SG; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Song GW; Jung DH
    Transplant Proc; 2009; 41(1):250-2. PubMed ID: 19249527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced amphotericin B nephrotoxicity in intensive care patients with elevated levels of low-density lipoprotein cholesterol.
    Wasan KM; Conklin JS
    Clin Infect Dis; 1997 Jan; 24(1):78-80. PubMed ID: 8994768
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin B.
    Bellmann R; Cleary JD; Sterba J
    Clin Adv Hematol Oncol; 2009 Apr; 7(4):1-8. PubMed ID: 19537331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply: Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.
    Huprikar S
    Liver Transpl; 2008 May; 14(5):709. PubMed ID: 18433053
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinical study of amphotericin B in the treatment of invasive fungal infection in 111 hematological disorder patients with neutrocytopenia].
    Tong HY; Zhang FJ; Xiao F; Qian WB; Meng HT; Mai WY; Tong Y; Mao LP; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2008 Jul; 29(7):472-5. PubMed ID: 19035181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetics of amphotericin B and its derivatives].
    Vetkina IF
    Antibiot Khimioter; 1991 Apr; 36(4):36-8. PubMed ID: 1892433
    [No Abstract]   [Full Text] [Related]  

  • 9. Mortality rates in comparative trials of formulations of amphotericin B.
    Frothingham R
    Clin Infect Dis; 2001 Aug; 33(4):582-3. PubMed ID: 11462201
    [No Abstract]   [Full Text] [Related]  

  • 10. Trichosporon asahii fatal infection in a non-neutropenic patient after orthotopic liver transplantation.
    Abdala E; Lopes RI; Chaves CN; Heins-Vaccari EM; Shikanai-Yasuda MA
    Transpl Infect Dis; 2005; 7(3-4):162-5. PubMed ID: 16390408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Amphotericin B: the end of an era].
    Rommes JH; Spronk PE; Saene HK
    Ned Tijdschr Geneeskd; 2005 Jan; 149(2):106; author reply 106-7. PubMed ID: 15688845
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost effectiveness of amphotericin B plus G-CSF compared with amphotericin B monotherapy. Treatment of presumed deep-seated fungal infection in neutropenic patients in the UK.
    Flynn TN; Kelsey SM; Hazel DL; Guest JF
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):543-50. PubMed ID: 10662479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amphotericin B lipid complex in the treatment of invasive fungal infections in liver transplant patients.
    Merhav H; Mieles L
    Transplant Proc; 1997 Sep; 29(6):2670-4. PubMed ID: 9290785
    [No Abstract]   [Full Text] [Related]  

  • 14. Caspofungin and amphotericin B for disseminated Fusarium verticillioides in leukemia.
    Makowsky MJ; Warkentin DI; Savoie ML
    Ann Pharmacother; 2005; 39(7-8):1365-6. PubMed ID: 15956243
    [No Abstract]   [Full Text] [Related]  

  • 15. Empiric antifungal therapy in the management of the febrile-granulocytopenic cancer patient.
    Commers JR; Pizzo PA
    Pediatr Infect Dis; 1983; 2(1):56-60. PubMed ID: 6835857
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical analysis of amphotericin B in the treatment of invasive fungal infections in 121 patients with hematologic diseases].
    Jia L; Huang M; Liu WL; Zhang YC; Sun HY; Zhang DH; Deng JN; Zhou JF
    Zhonghua Xue Ye Xue Za Zhi; 2008 Sep; 29(9):619-22. PubMed ID: 19175991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis and treatment of fungal infection after liver transplantation.
    Shi XJ; Lü SC; He L; Lu F; Liang YR; Luo Y; Ji WB; Zhao ZM
    Chin Med J (Engl); 2011 Apr; 124(7):1015-7. PubMed ID: 21542960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation.
    Krüger W; Stockschläder M; Rüssmann B; Berger C; Hoffknecht M; Sobottka I; Kohlschütter B; Kroschke G; Kröger N; Horstmann M
    Br J Haematol; 1995 Nov; 91(3):684-90. PubMed ID: 8555076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of amphotericin B lipid complex in 15 patients with presumed or proven fungal infection.
    Allsup D; Chu P
    Br J Haematol; 1998 Sep; 102(4):1109-10. PubMed ID: 9734667
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients.
    Reed A; Herndon JB; Ersoz N; Fujikawa T; Schain D; Lipori P; Hemming A; Li Q; Shenkman E; Vogel B
    Liver Transpl; 2007 Dec; 13(12):1743-50. PubMed ID: 18044769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.